AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+9.75%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(-0.95%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-10.77%
Top 10 Holdings %
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
32
Reduced
137
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$2.73M |
| 2 |
Indivior
INDV
|
$2.36M |
| 3 |
Alphatec Holdings
ATEC
|
$2.06M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.79M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$1.37M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$4.17M |
| 2 |
Pacira BioSciences
PCRX
|
$3.36M |
| 3 |
Pfizer
PFE
|
$3.04M |
| 4 |
United Therapeutics
UTHR
|
$2.96M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$2.13M |
Sector Composition
| 1 | Healthcare | 57.92% |
| 2 | Real Estate | 14.45% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 3.2% |
| 5 | Technology | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cadence Design Systems
CDNS
$94.6B
| $339K | 0.25% |
+1,250
| New | +$339K |
|
102
Vera Therapeutics
VERA
$1.47B
| $332K | 0.25% |
+7,500
| New | +$332K |
|
103
Jasper Therapeutics
JSPR
$44.2M
| $329K | 0.24% |
+17,500
| New | +$329K |
|
|
SAFE
104
Safehold
SAFE
$1.16B
| $314K | 0.23% |
11,972
| – | – |
|
105
Synchrony
SYF
$28.1B
| $311K | 0.23% |
6,243
-192
| -3% | -$9.58K |
|
106
Nuvation Bio
NUVB
$1.08B
| $309K | 0.23% |
135,000
| – | – |
|
107
United Airlines
UAL
$34.4B
| $297K | 0.22% |
5,213
-189
| -3% | -$10.8K |
|
108
Gilead Sciences
GILD
$140B
| $293K | 0.22% |
3,500
| – | – |
|
109
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $287K | 0.21% |
+11,478
| New | +$287K |
|
110
Immatics
IMTX
$662M
| $285K | 0.21% |
25,000
+5,000
| +25% | +$57.1K |
|
111
DexCom
DXCM
$30.9B
| $280K | 0.21% |
+4,171
| New | +$280K |
|
112
PACCAR
PCAR
$50.5B
| $273K | 0.2% |
2,769
-88
| -3% | -$8.68K |
|
113
Everest Group
EG
$14.6B
| $249K | 0.19% |
636
-23
| -3% | -$9.01K |
|
114
Kinross Gold
KGC
$26.6B
| $245K | 0.18% |
26,181
-647
| -2% | -$6.06K |
|
115
iShares US & Intl High Yield Corp Bond ETF
GHYG
$175M
| $243K | 0.18% |
5,312
-58
| -1% | -$2.66K |
|
116
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.24B
| $243K | 0.18% |
5,827
-16
| -0.3% | -$667 |
|
117
SPDR Bloomberg High Yield Bond ETF
JNK
$8.07B
| $243K | 0.18% |
2,482
-22
| -0.9% | -$2.15K |
|
118
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.25B
| $242K | 0.18% |
5,583
-16
| -0.3% | -$695 |
|
119
iShares Fallen Angels USD Bond ETF
FALN
$1.86B
| $242K | 0.18% |
8,857
-79
| -0.9% | -$2.16K |
|
120
Pultegroup
PHM
$26.3B
| $240K | 0.18% |
1,670
-63
| -4% | -$9.04K |
|
121
Tenet Healthcare
THC
$16.5B
| $237K | 0.18% |
1,426
-40
| -3% | -$6.65K |
|
122
DaVita
DVA
$9.72B
| $229K | 0.17% |
1,396
-55
| -4% | -$9.02K |
|
|
CIM
123
Chimera Investment
CIM
$1.15B
| $222K | 0.17% |
14,022
-1
| -0% | -$16 |
|
124
Viking Therapeutics
VKTX
$3.02B
| $222K | 0.16% |
3,500
-13,000
| -79% | -$823K |
|
125
Cintas
CTAS
$82.9B
| $208K | 0.15% |
1,012
+741
| +273% | -$14.8K |
|